TXG (STOCKS)
10x Genomics, Inc. Class A Common Stock
$32.680000
+3.840000 (+13.31%)
Prev close: $28.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Serge Saxonov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,093.07M
- Employees
- 1,306
- P/E (TTM)
- -165.37
- P/B (TTM)
- 4.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
4
Buy
12
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.10 | $-0.29 | +0.1945 | +66.04% |
|
Dec 2025 (Q4)
|
$-0.13 | $-0.21 | +0.0846 | +39.42% |
|
Sep 2025 (Q3)
|
$-0.22 | $-0.29 | +0.0710 | +24.40% |
|
Jun 2025 (Q2)
|
$0.28 | $-0.38 | +0.6553 | +174.61% |
Financial Statements
| Revenues | $638.78M |
| Benefits Costs and Expenses | $658.03M |
| Cost Of Revenue | $194.17M |
| Costs And Expenses | $658.03M |
| Gross Profit | $444.61M |
| Nonoperating Income/Loss | $19.46M |
| Operating Expenses | $483.32M |
| Selling, General, and Administrative Expenses | $292.78M |
| Other Operating Expenses | $190.53M |
| Operating Income/Loss | -$38.70M |
| Income/Loss From Continuing Operations After Tax | -$22.66M |
| Income/Loss From Continuing Operations Before Tax | -$19.25M |
| Income Tax Expense/Benefit | $3.41M |
| Net Income/Loss | -$22.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.17 |
| Diluted Earnings Per Share | -$0.17 |
| Basic Average Shares | 378,333,533 |
| Diluted Average Shares | 379,087,844 |
| Assets | $1.02B |
| Current Assets | $669.73M |
| Inventory | $53.49M |
| Other Current Assets | $616.25M |
| Noncurrent Assets | $346.03M |
| Fixed Assets | $220.59M |
| Intangible Assets | $59.91M |
| Other Non-current Assets | $65.53M |
| Liabilities | $201.44M |
| Current Liabilities | $113.60M |
| Accounts Payable | $17.43M |
| Wages | $21.51M |
| Other Current Liabilities | $74.67M |
| Noncurrent Liabilities | $87.84M |
| Equity | $814.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $814.32M |
| Liabilities And Equity | $1.02B |
| Net Cash Flow From Operating Activities | $127.82M |
| Net Cash Flow From Operating Activities, Continuing | $127.82M |
| Net Cash Flow From Investing Activities | -$12.86M |
| Net Cash Flow From Investing Activities, Continuing | -$12.86M |
| Net Cash Flow From Financing Activities | -$2.04M |
| Net Cash Flow From Financing Activities, Continuing | -$2.04M |
| Exchange Gains/Losses | $297.00K |
| Net Cash Flow | $113.22M |
| Net Cash Flow, Continuing | $112.93M |
| Comprehensive Income/Loss | -$22.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.18M |
| Other Comprehensive Income/Loss | -$57.30M |
| Other Comprehensive Income/Loss Attributable To Parent | $481.00K |